{"id":388,"date":"2017-09-25T16:10:43","date_gmt":"2017-09-25T08:10:43","guid":{"rendered":"https:\/\/credevo.com\/articles\/\/?p=388"},"modified":"2024-10-24T22:51:45","modified_gmt":"2024-10-24T14:51:45","slug":"south-korea-clinical-trials-regulatory-process","status":"publish","type":"post","link":"https:\/\/credevo.com\/articles\/2017\/09\/25\/south-korea-clinical-trials-regulatory-process\/","title":{"rendered":"South Korea &#8211; Clinical Trials Regulatory Process"},"content":{"rendered":"\n<p><span data-preserver-spaces=\"true\">With a population of over 51.75 million people, South Korea offers a diverse patient population with a range of medical conditions, making it an ideal location for conducting clinical trials with a broad range of participants. Additionally, the country has a well-developed healthcare system and skilled workforce, making it an attractive location for clinical research.<\/span> South Korea has a long history of conducting global clinical trials than most other Asian countries including, Japan.<\/p>\n\n\n\n<h5 class=\"wp-block-heading\"><em>This article was last updated in O<\/em>ct<em> 202<\/em>4<em>.<\/em><\/h5>\n\n\n\n<figure class=\"wp-block-image\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"548\" src=\"https:\/\/credevo.com\/articles\/\/wp-content\/uploads\/2017\/09\/South_Korea_Clinical_Trial_Regulatory_Process_Credevo_-1024x548.jpg\" alt=\"South Korea clinical trial approval process\" class=\"wp-image-426\" srcset=\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2017\/09\/South_Korea_Clinical_Trial_Regulatory_Process_Credevo_-1024x548.jpg 1024w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2017\/09\/South_Korea_Clinical_Trial_Regulatory_Process_Credevo_-300x161.jpg 300w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2017\/09\/South_Korea_Clinical_Trial_Regulatory_Process_Credevo_-768x411.jpg 768w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2017\/09\/South_Korea_Clinical_Trial_Regulatory_Process_Credevo_-732x392.jpg 732w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2017\/09\/South_Korea_Clinical_Trial_Regulatory_Process_Credevo_-1140x610.jpg 1140w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2017\/09\/South_Korea_Clinical_Trial_Regulatory_Process_Credevo_.jpg 1920w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\"><span style=\"font-weight: 400;\">Why South Korea for your clinical trials?<\/span><\/h2>\n\n\n\n<p>According to <a href=\"https:\/\/clinicaltrials.gov\/search?locStr=South%20Korea&amp;country=South%20Korea&amp;aggFilters=status:not%20rec\" target=\"_blank\" rel=\"noreferrer noopener\">ClinicalTrials.go<\/a>v, as of October 2024, a total of 15,658 clinical trials have been conducted in South Korea, with 2,150 ongoing. This indicates that South Korea is a popular destination for clinical trials, and many global pharmaceutical and biotech companies are conducting clinical trials in the country.<\/p>\n\n\n\n<p>South Korea conducts diverse types of clinical trials that cover various therapeutic areas, including.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>oncology, <\/li>\n\n\n\n<li>cardiology, <\/li>\n\n\n\n<li>neurology, and <\/li>\n\n\n\n<li>infectious diseases, among others.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span data-preserver-spaces=\"true\">Top 5 Advantages of conducting clinical trials in South Korea<\/span><\/h2>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Skilled Medical Infrastructure<\/strong>: Advanced hospitals and well-trained professionals ensure high-quality trials.<\/li>\n\n\n\n<li><strong>Efficient Regulatory Process<\/strong>: Faster approvals from the MFDS make starting trials quicker.<\/li>\n\n\n\n<li><strong>Diverse Patient Pool<\/strong>: Easy recruitment due to universal healthcare and accessible patient records.<\/li>\n\n\n\n<li><strong>Government Support<\/strong>: Incentives and funding make trials more cost-effective.<\/li>\n\n\n\n<li><strong>High Data Integrity<\/strong>: Strong adherence to global standards ensures reliable, high-quality data.<\/li>\n<\/ol>\n\n\n\n<p>All of these factors contribute to a country with one of the shortest startup times in Asia.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-css-opacity is-style-wide\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">Need support for conducting your clinical trials in South Korea?<\/h3>\n\n\n\n<p>Credevo offers expertise in drug product registration, clinical trial regulations, and many more services in South Korea. Provide the details of your requirements in the form below to connect with us.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-css-opacity is-style-wide\"\/>\n\n\n\n<p>Along with these above facts, there are also some challenges while conducting clinical trials in South Korea<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Top 3 Challenges with clinical trials in South Korea<\/h3>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Patient Recruitment:<\/strong> Despite having a large patient population, patient recruitment can be challenging in South Korea, particularly for trials involving rare diseases or specific patient populations. This is because patients may be hesitant to participate in clinical trials due to cultural beliefs, language barriers, or concerns about privacy.<\/li>\n\n\n\n<li><strong>Competition from Other Countries:<\/strong> South Korea faces stiff competition from other countries, such as China and Japan, which are also popular destinations for clinical trials. This competition can lead to challenges in attracting sponsors and investment for clinical trials.<\/li>\n\n\n\n<li><strong>Regulatory Hurdles:<\/strong> Although South Korea has a well-established regulatory framework for clinical trials, navigating the regulatory environment can be challenging for researchers and sponsors. The process of obtaining regulatory approval for clinical trials in South Korea can be time-consuming and complex, leading to delays and additional costs.<\/li>\n<\/ol>\n\n\n\n<p>Here is where credevo can help you in conducting your clinical trial in South Korea. Contact us at <a href=\"mailto:inquiry@credevo.com\">inquiry@credevo.com<\/a> or fill out the form below to get support for clinical trials in South Korea.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span style=\"font-weight: 400;\">Clinical trial regulatory process in South Korea<\/span><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">The Korean <\/span><b><a href=\"https:\/\/www.mfds.go.kr\/eng\/index.do\" target=\"_blank\" rel=\"noreferrer noopener\">Ministry of Food and Drug Safety (MFDS)<\/a>, <\/b><span style=\"font-weight: 400;\">formerly known as the<\/span><b> <a href=\"https:\/\/www.mfds.go.kr\/eng\/index.do\" target=\"_blank\" rel=\"noreferrer noopener\">Korea Food &amp; Drug Administration (KFDA)<\/a>, <\/b><span style=\"font-weight: 400;\">is the main regulatory body for drugs, medical devices, food, and cosmetic products.<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">The MFDS provides pre-investigational new drug consultation services.<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">To conduct a clinical trial in South Korea, the sponsor must obtain <\/span><b>institutional review board (IRB)<\/b><span style=\"font-weight: 400;\"> approval. \u00a0<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">The sponsor should submit a clinical trial application and translate all the appropriate supporting documents into Korean. <\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">The IRB approval process can take 1-2 months in Korea.<\/span><\/li>\n<\/ul>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p><a href=\"https:\/\/credevo.com\/articles\/2020\/02\/15\/rare-diseases-regulatory-incentives-for-development-of-orphan-drugs-china-india-russia-south-korea\/\"><em>Click here to learn about orphan drug regulatory benefits and financial incentives provided by South Korean regulatory<\/em><\/a><\/p>\n<\/blockquote>\n\n\n\n<h2 class=\"wp-block-heading\"><span style=\"font-weight: 400;\">Requirements to obtain approval for clinical trial initiation<\/span><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><span style=\"font-weight: 400;\">Clinical Trials for medical devices in Korea<\/span><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span data-preserver-spaces=\"true\">Foreign companies must first prepare a clinical investigation plan and provide documents proving that their manufacturing facility meets GMP standards to submit a clinical trial application for a medical device in Korea.<\/span><\/li>\n\n\n\n<li><span data-preserver-spaces=\"true\">If the device is used to treat life-threatening illnesses, a series of supplementary documents must be approved by the Investigational Review Board (IRB). <\/span><\/li>\n\n\n\n<li><span data-preserver-spaces=\"true\">Medical device trials generally receive approval in Korea within 30 days.<\/span><\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span style=\"font-weight: 400;\">Clinical Trials for Pharmaceuticals in Korea<\/span><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">Companies must go through the <strong>Clinical Trial Authorization (CTA)<\/strong> process. <\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Before beginning the pharmaceutical clinical trial in Korea, applicants must choose trial sites and a Principal Investigator (PI). <\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Korean PIs must be well educated, trained, and have foreign language abilities. <\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">The sponsor and head of the clinical trial site will sign a written contract before the trial begins. <\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">If the sponsor uses a CRO, they must write a contract outlining a set of tasks for the CRO to complete.<\/span><\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span style=\"font-weight: 400;\">Local Representative<\/span><\/h3>\n\n\n\n<p>To obtain approval of a clinical trial protocol in South Korea, a foreign company without an established presence in Korea must delegate all rights and responsibilities for the execution of the clinical trial through an agreement with a contract research organization (CRO) established in Korea.<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p><em>Do you have any queries or looking for regulatory support in various stages of drug development? talk to us at <a href=\"mailto:inquiry@credevo.com\">inquiry@credevo.com<\/a> or provide your query details in the below form<\/em><\/p>\n<\/blockquote>\n\n\n\n<h3 class=\"wp-block-heading\"><span style=\"font-weight: 400;\">Electronic Filing System (KiFDA)<\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">Korea\u2019s drug clinical trial approval forms can now be submitted through the e-registration system. Applicants and CROs can self-register their products after receiving approval.<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span style=\"font-weight: 400;\">CRIS (Clinical Research Information Services)<\/span><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span data-preserver-spaces=\"true\">The South Korean government developed a web-based platform called CRIS (Clinical Research Information Services) to facilitate the management of clinical trial information.<\/span><\/li>\n\n\n\n<li><span data-preserver-spaces=\"true\">It is a central database that provides information on ongoing clinical trials conducted in South Korea.<\/span><\/li>\n\n\n\n<li>The CRIS includes any clinical trial or research that will prospectively be conducted with human participants, aiming to prevent, detect, diagnose, or treat diseases.\u00a0<\/li>\n\n\n\n<li>The IRB should approve the clinical trial before registering it on the CRIS. <\/li>\n\n\n\n<li>The Korea Centers for Disease Control and Prevention (KCDC), with support from the Ministry of Health and Welfare (MOHW), established the CRIS.<\/li>\n\n\n\n<li>It joined the WHO International Clinical Trials Registry Platform (ICTRP) as an 11th member of the <span data-preserver-spaces=\"true\">Primary Registry.<\/span><\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span style=\"font-weight: 400;\">Parallel approval process<\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">In South Korea, the application process for both CTA and IRB is parallel.<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Step by step clinical trial approval process in South Korea<\/h2>\n\n\n\n<p>The clinical trial approval process in South Korea involves several steps, which include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Submission of the clinical trial application: <\/strong>The first step in the approval process is to submit a clinical trial application to the Ministry of Food and Drug Safety (MFDS). The application should include details of the trial protocol, including the study design, objectives, inclusion\/exclusion criteria, and endpoints.<\/li>\n\n\n\n<li><strong>Ethical review:<\/strong> The Ministry of Food and Drug Safety (MFDS) forwards the application to the Institutional Review Board (IRB) for ethical review once they receive it. The IRB is responsible for reviewing the study protocol to ensure that it meets ethical standards and protects the rights and welfare of study participants.<\/li>\n\n\n\n<li><strong>Regulatory review:<\/strong> After receiving ethical approval, the MFDS conducts a regulatory review of the clinical trial application. The regulatory review includes an assessment of the scientific validity of the study, as well as a review of the safety and efficacy data.<\/li>\n\n\n\n<li><strong>Approval decision:<\/strong> Once the regulatory review is complete, the MFDS makes a decision on whether to approve the clinical trial application. If the Ministry of Food and Drug Safety (MFDS) approves the application, the sponsor may proceed with the trial.<\/li>\n\n\n\n<li><strong>Post-approval reporting:<\/strong> After approval, sponsors must submit regular reports on the progress of the trial to the MFDS. This includes safety reports, interim analysis reports, and final study reports.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span style=\"font-weight: 400;\">Time of approval<\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">The process for regulatory approval takes about 30 days and for IRB, it takes about 50 days.<\/span><\/p>\n\n\n\n<figure class=\"wp-block-image\"><img loading=\"lazy\" decoding=\"async\" width=\"960\" height=\"720\" src=\"https:\/\/credevo.com\/articles\/\/wp-content\/uploads\/2017\/11\/South_Korea_Clinical_Trial_Approval_Process_Credevo_.jpg\" alt=\"South_Korea_Clinical_Trial_Approval_Process_Credevo\" class=\"wp-image-418\" srcset=\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2017\/11\/South_Korea_Clinical_Trial_Approval_Process_Credevo_.jpg 960w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2017\/11\/South_Korea_Clinical_Trial_Approval_Process_Credevo_-300x225.jpg 300w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2017\/11\/South_Korea_Clinical_Trial_Approval_Process_Credevo_-768x576.jpg 768w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2017\/11\/South_Korea_Clinical_Trial_Approval_Process_Credevo_-732x549.jpg 732w\" sizes=\"(max-width: 960px) 100vw, 960px\" \/><\/figure>\n\n\n\n<h6 class=\"wp-block-heading has-text-align-center\">Legends:&nbsp;<span style=\"font-weight: 400;\">ICF-informed Consent Form; IB-investigator Brochure; CRF-case Report Form; CMC-chemistry, Manufacturing, And Controls<\/span><\/h6>\n\n\n\n<hr class=\"wp-block-separator has-css-opacity is-style-wide\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><span style=\"font-weight: 400;\">Guidelines for clinical trial approval (CTA) for drugs<\/span><\/h2>\n\n\n\n<p>See the <a href=\"https:\/\/www.nihcollaboratory.org\/sites\/CbyC\/Document%20Library\/KFDAguidelines.pdf\">guidelines here<\/a><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span style=\"font-weight: 400;\">Documents required for clinical trial approval<\/span><\/h3>\n\n\n\n<ol class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">Development Plan<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Introduction<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Data on the evidence of chemical structure and the physicochemical and biological properties (including a placebo)<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Non-clinical tests<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Clinical trial<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Clinical trial protocol<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Investigator&#8217;s Brochure<\/span><\/li>\n<\/ol>\n\n\n\n<h2 class=\"wp-block-heading\"><span style=\"font-weight: 400;\">Exemption from submission of data for the category of drugs below<\/span><\/h2>\n\n\n\n<p>KFDA provides some exemptions for the submission of data for some categories of drugs as below<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span data-preserver-spaces=\"true\">A drug is <\/span>under development in Korea for the first time in the world.<\/li>\n\n\n\n<li>A drug is under development in any foreign country.<\/li>\n\n\n\n<li>Prior consultation with the Commissioner of KFDA as provided in Article 14, and acknowledgment of appropriateness, allows the applicant to apply for Clinical Study Authorization.<\/li>\n\n\n\n<li>This applies to clinical trials conducted for meeting permit conditions after the drug&#8217;s license is issued.<\/li>\n\n\n\n<li>An orphan drug.<\/li>\n\n\n\n<li>A drug with adequate clinical evidence in Korea and foreign countries, if the applicant plans to begin a confirmatory clinical trial associated with licensing the drug, including any amendments.<\/li>\n\n\n\n<li>A new drug made from natural substances, excluding cases where any characteristic component is separated and extracted, is the subject of reference.<\/li>\n\n\n\n<li>A new drug with a component(s) used in Korea before but with different indications, usage, posology, method of administration, composition, formulation, and\/or administration route, and safe to use.<\/li>\n\n\n\n<li>The Commissioner of KFDA separately acknowledges other drugs.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span style=\"font-weight: 400;\">Import of investigational medicines<\/span><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span data-preserver-spaces=\"true\">Before shipping the investigational product into Korea, the sponsor needs to obtain an import permit. <\/span><\/li>\n\n\n\n<li><span data-preserver-spaces=\"true\">After clinical trial application approval, the Korea Pharmaceutical Traders Association (KPTA) authorized by the MFDS, issues the permit for imported pharmaceuticals, cosmetics, and herbal medicines.<\/span><\/li>\n\n\n\n<li><span data-preserver-spaces=\"true\">The process uses the Electronic Data Interchange of the Korea Customs Service.<\/span><\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span style=\"font-weight: 400;\">Procedural requirements<\/span><\/h3>\n\n\n\n<p>Clinical trials must be conducted following the standards under the Good Clinical Practices for pharmaceutical products and medical devices.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-css-opacity\"\/>\n\n\n\n<blockquote class=\"wp-block-quote\"><h1><strong>Are you looking for clinical trial regulatory support&nbsp;<\/strong><\/h1><p>Talk to us today. Provide details of your requirements and we will connect with you.<\/p><\/blockquote>\n\n\n<div class=\"wpforms-container wpforms-container-full\" id=\"wpforms-2811\"><form id=\"wpforms-form-2811\" class=\"wpforms-validate wpforms-form\" data-formid=\"2811\" method=\"post\" enctype=\"multipart\/form-data\" action=\"\/articles\/wp-json\/wp\/v2\/posts\/388\" data-token=\"b53ef966abf77b33a4b0d57ba096b8e8\" data-token-time=\"1776634395\"><noscript class=\"wpforms-error-noscript\">Please enable JavaScript in your browser to complete this form.<\/noscript><div class=\"wpforms-field-container\"><div id=\"wpforms-2811-field_7-container\" class=\"wpforms-field wpforms-field-textarea\" data-field-id=\"7\"><label class=\"wpforms-field-label\" for=\"wpforms-2811-field_7\">Provide introductory details of your requirement. <span class=\"wpforms-required-label\">*<\/span><\/label><textarea id=\"wpforms-2811-field_7\" class=\"wpforms-field-medium wpforms-field-required\" name=\"wpforms[fields][7]\" required><\/textarea><div class=\"wpforms-field-description\">Provide brief info on your requirements.<\/div><\/div><div id=\"wpforms-2811-field_11-container\" class=\"wpforms-field wpforms-field-text\" data-field-id=\"11\"><label class=\"wpforms-field-label\" for=\"wpforms-2811-field_11\">What is your Company \/ Organization name? <span class=\"wpforms-required-label\">*<\/span><\/label><input type=\"text\" id=\"wpforms-2811-field_11\" class=\"wpforms-field-medium wpforms-field-required\" name=\"wpforms[fields][11]\" required><\/div><div id=\"wpforms-2811-field_12-container\" class=\"wpforms-field wpforms-field-email\" data-field-id=\"12\"><label class=\"wpforms-field-label\" for=\"wpforms-2811-field_12\">What is your work email? <span class=\"wpforms-required-label\">*<\/span><\/label><input type=\"email\" id=\"wpforms-2811-field_12\" class=\"wpforms-field-medium wpforms-field-required\" name=\"wpforms[fields][12]\" spellcheck=\"false\" required><\/div><\/div><!-- .wpforms-field-container --><div class=\"wpforms-field wpforms-field-hp\"><label for=\"wpforms-2811-field-hp\" class=\"wpforms-field-label\">Name<\/label><input type=\"text\" name=\"wpforms[hp]\" id=\"wpforms-2811-field-hp\" class=\"wpforms-field-medium\"><\/div><div class=\"wpforms-recaptcha-container wpforms-is-recaptcha wpforms-is-recaptcha-type-v2\" ><div class=\"g-recaptcha\" data-sitekey=\"6LeaQRYTAAAAAPo7U8jnZJBUndxcS3f0E3Vijb2k\"><\/div><input type=\"text\" name=\"g-recaptcha-hidden\" class=\"wpforms-recaptcha-hidden\" style=\"position:absolute!important;clip:rect(0,0,0,0)!important;height:1px!important;width:1px!important;border:0!important;overflow:hidden!important;padding:0!important;margin:0!important;\" data-rule-recaptcha=\"1\"><\/div><div class=\"wpforms-submit-container\" ><input type=\"hidden\" name=\"wpforms[id]\" value=\"2811\"><input type=\"hidden\" name=\"page_title\" value=\"\"><input type=\"hidden\" name=\"page_url\" value=\"https:\/\/credevo.com\/articles\/wp-json\/wp\/v2\/posts\/388\"><input type=\"hidden\" name=\"url_referer\" value=\"\"><button type=\"submit\" name=\"wpforms[submit]\" id=\"wpforms-submit-2811\" class=\"wpforms-submit\" data-alt-text=\"Sending...\" data-submit-text=\"Submit\" aria-live=\"assertive\" value=\"wpforms-submit\">Submit<\/button><\/div><\/form><\/div>  <!-- .wpforms-container -->\n\n\n\n<hr class=\"wp-block-separator has-css-opacity\"\/>\n","protected":false},"excerpt":{"rendered":"<p>With a population of over 51.75 million people, South Korea offers a diverse patient population with a range of medical conditions, making it an ideal location for conducting clinical trials with a broad range of participants. Additionally, the country has a well-developed healthcare system and skilled workforce, making it an attractive location for clinical research. [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":426,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"cybocfi_hide_featured_image":"","footnotes":""},"categories":[566,4],"tags":[267,598,71],"class_list":["post-388","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-clinical-development","category-regulatory","tag-clinical-trial","tag-mfds","tag-southkorea"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Regulatory process for conducting clinical trials in South Korea<\/title>\n<meta name=\"description\" content=\"More than 80% of clinical trials in South Korea are global, which is a great indicator of the suitability of South Korea as a clinical trial destination.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/credevo.com\/articles\/2017\/09\/25\/south-korea-clinical-trials-regulatory-process\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Regulatory process for conducting clinical trials in South Korea\" \/>\n<meta property=\"og:description\" content=\"More than 80% of clinical trials in South Korea are global, which is a great indicator of the suitability of South Korea as a clinical trial destination.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/credevo.com\/articles\/2017\/09\/25\/south-korea-clinical-trials-regulatory-process\/\" \/>\n<meta property=\"og:site_name\" content=\"Credevo Articles\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/credevo\" \/>\n<meta property=\"article:published_time\" content=\"2017-09-25T08:10:43+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-24T14:51:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2017\/09\/South_Korea_Clinical_Trial_Regulatory_Process_Credevo_.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1028\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Feasibility Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@gocredevo\" \/>\n<meta name=\"twitter:site\" content=\"@gocredevo\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Feasibility Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/credevo.com\/articles\/2017\/09\/25\/south-korea-clinical-trials-regulatory-process\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/credevo.com\/articles\/2017\/09\/25\/south-korea-clinical-trials-regulatory-process\/\"},\"author\":{\"name\":\"Feasibility Team\",\"@id\":\"https:\/\/credevo.com\/articles\/#\/schema\/person\/eaf79e204cf3f6b11d8925cdd7adb3ed\"},\"headline\":\"South Korea &#8211; Clinical Trials Regulatory Process\",\"datePublished\":\"2017-09-25T08:10:43+00:00\",\"dateModified\":\"2024-10-24T14:51:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/credevo.com\/articles\/2017\/09\/25\/south-korea-clinical-trials-regulatory-process\/\"},\"wordCount\":1594,\"publisher\":{\"@id\":\"https:\/\/credevo.com\/articles\/#organization\"},\"image\":{\"@id\":\"https:\/\/credevo.com\/articles\/2017\/09\/25\/south-korea-clinical-trials-regulatory-process\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2017\/09\/South_Korea_Clinical_Trial_Regulatory_Process_Credevo_.jpg\",\"keywords\":[\"clinical trial\",\"MFDS\",\"southkorea\"],\"articleSection\":[\"Clinical Development\",\"Regulatory\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/credevo.com\/articles\/2017\/09\/25\/south-korea-clinical-trials-regulatory-process\/\",\"url\":\"https:\/\/credevo.com\/articles\/2017\/09\/25\/south-korea-clinical-trials-regulatory-process\/\",\"name\":\"Regulatory process for conducting clinical trials in South Korea\",\"isPartOf\":{\"@id\":\"https:\/\/credevo.com\/articles\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/credevo.com\/articles\/2017\/09\/25\/south-korea-clinical-trials-regulatory-process\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/credevo.com\/articles\/2017\/09\/25\/south-korea-clinical-trials-regulatory-process\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2017\/09\/South_Korea_Clinical_Trial_Regulatory_Process_Credevo_.jpg\",\"datePublished\":\"2017-09-25T08:10:43+00:00\",\"dateModified\":\"2024-10-24T14:51:45+00:00\",\"description\":\"More than 80% of clinical trials in South Korea are global, which is a great indicator of the suitability of South Korea as a clinical trial destination.\",\"breadcrumb\":{\"@id\":\"https:\/\/credevo.com\/articles\/2017\/09\/25\/south-korea-clinical-trials-regulatory-process\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/credevo.com\/articles\/2017\/09\/25\/south-korea-clinical-trials-regulatory-process\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/credevo.com\/articles\/2017\/09\/25\/south-korea-clinical-trials-regulatory-process\/#primaryimage\",\"url\":\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2017\/09\/South_Korea_Clinical_Trial_Regulatory_Process_Credevo_.jpg\",\"contentUrl\":\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2017\/09\/South_Korea_Clinical_Trial_Regulatory_Process_Credevo_.jpg\",\"width\":1920,\"height\":1028,\"caption\":\"South Korea clinical trial approval process\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/credevo.com\/articles\/2017\/09\/25\/south-korea-clinical-trials-regulatory-process\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/credevo.com\/articles\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"South Korea &#8211; Clinical Trials Regulatory Process\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/credevo.com\/articles\/#website\",\"url\":\"https:\/\/credevo.com\/articles\/\",\"name\":\"Credevo\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/credevo.com\/articles\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/credevo.com\/articles\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/credevo.com\/articles\/#organization\",\"name\":\"Credevo Pte. Ltd.\",\"url\":\"https:\/\/credevo.com\/articles\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/credevo.com\/articles\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2021\/04\/CREDEVO-HORIZONTAL.jpg\",\"contentUrl\":\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2021\/04\/CREDEVO-HORIZONTAL.jpg\",\"width\":320,\"height\":119,\"caption\":\"Credevo Pte. Ltd.\"},\"image\":{\"@id\":\"https:\/\/credevo.com\/articles\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/credevo\",\"https:\/\/x.com\/gocredevo\",\"https:\/\/www.instagram.com\/credevo_official\/\",\"https:\/\/www.linkedin.com\/company\/credevo\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/credevo.com\/articles\/#\/schema\/person\/eaf79e204cf3f6b11d8925cdd7adb3ed\",\"name\":\"Feasibility Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/credevo.com\/articles\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/0f5b3e164715f8b2e66af0b776460d63?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/0f5b3e164715f8b2e66af0b776460d63?s=96&d=mm&r=g\",\"caption\":\"Feasibility Team\"},\"sameAs\":[\"http:\/\/www.credevo.com\"],\"url\":\"https:\/\/credevo.com\/articles\/author\/fteam\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Regulatory process for conducting clinical trials in South Korea","description":"More than 80% of clinical trials in South Korea are global, which is a great indicator of the suitability of South Korea as a clinical trial destination.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/credevo.com\/articles\/2017\/09\/25\/south-korea-clinical-trials-regulatory-process\/","og_locale":"en_US","og_type":"article","og_title":"Regulatory process for conducting clinical trials in South Korea","og_description":"More than 80% of clinical trials in South Korea are global, which is a great indicator of the suitability of South Korea as a clinical trial destination.","og_url":"https:\/\/credevo.com\/articles\/2017\/09\/25\/south-korea-clinical-trials-regulatory-process\/","og_site_name":"Credevo Articles","article_publisher":"https:\/\/www.facebook.com\/credevo","article_published_time":"2017-09-25T08:10:43+00:00","article_modified_time":"2024-10-24T14:51:45+00:00","og_image":[{"width":1920,"height":1028,"url":"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2017\/09\/South_Korea_Clinical_Trial_Regulatory_Process_Credevo_.jpg","type":"image\/jpeg"}],"author":"Feasibility Team","twitter_card":"summary_large_image","twitter_creator":"@gocredevo","twitter_site":"@gocredevo","twitter_misc":{"Written by":"Feasibility Team","Est. reading time":"8 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/credevo.com\/articles\/2017\/09\/25\/south-korea-clinical-trials-regulatory-process\/#article","isPartOf":{"@id":"https:\/\/credevo.com\/articles\/2017\/09\/25\/south-korea-clinical-trials-regulatory-process\/"},"author":{"name":"Feasibility Team","@id":"https:\/\/credevo.com\/articles\/#\/schema\/person\/eaf79e204cf3f6b11d8925cdd7adb3ed"},"headline":"South Korea &#8211; Clinical Trials Regulatory Process","datePublished":"2017-09-25T08:10:43+00:00","dateModified":"2024-10-24T14:51:45+00:00","mainEntityOfPage":{"@id":"https:\/\/credevo.com\/articles\/2017\/09\/25\/south-korea-clinical-trials-regulatory-process\/"},"wordCount":1594,"publisher":{"@id":"https:\/\/credevo.com\/articles\/#organization"},"image":{"@id":"https:\/\/credevo.com\/articles\/2017\/09\/25\/south-korea-clinical-trials-regulatory-process\/#primaryimage"},"thumbnailUrl":"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2017\/09\/South_Korea_Clinical_Trial_Regulatory_Process_Credevo_.jpg","keywords":["clinical trial","MFDS","southkorea"],"articleSection":["Clinical Development","Regulatory"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/credevo.com\/articles\/2017\/09\/25\/south-korea-clinical-trials-regulatory-process\/","url":"https:\/\/credevo.com\/articles\/2017\/09\/25\/south-korea-clinical-trials-regulatory-process\/","name":"Regulatory process for conducting clinical trials in South Korea","isPartOf":{"@id":"https:\/\/credevo.com\/articles\/#website"},"primaryImageOfPage":{"@id":"https:\/\/credevo.com\/articles\/2017\/09\/25\/south-korea-clinical-trials-regulatory-process\/#primaryimage"},"image":{"@id":"https:\/\/credevo.com\/articles\/2017\/09\/25\/south-korea-clinical-trials-regulatory-process\/#primaryimage"},"thumbnailUrl":"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2017\/09\/South_Korea_Clinical_Trial_Regulatory_Process_Credevo_.jpg","datePublished":"2017-09-25T08:10:43+00:00","dateModified":"2024-10-24T14:51:45+00:00","description":"More than 80% of clinical trials in South Korea are global, which is a great indicator of the suitability of South Korea as a clinical trial destination.","breadcrumb":{"@id":"https:\/\/credevo.com\/articles\/2017\/09\/25\/south-korea-clinical-trials-regulatory-process\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/credevo.com\/articles\/2017\/09\/25\/south-korea-clinical-trials-regulatory-process\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/credevo.com\/articles\/2017\/09\/25\/south-korea-clinical-trials-regulatory-process\/#primaryimage","url":"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2017\/09\/South_Korea_Clinical_Trial_Regulatory_Process_Credevo_.jpg","contentUrl":"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2017\/09\/South_Korea_Clinical_Trial_Regulatory_Process_Credevo_.jpg","width":1920,"height":1028,"caption":"South Korea clinical trial approval process"},{"@type":"BreadcrumbList","@id":"https:\/\/credevo.com\/articles\/2017\/09\/25\/south-korea-clinical-trials-regulatory-process\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/credevo.com\/articles\/"},{"@type":"ListItem","position":2,"name":"South Korea &#8211; Clinical Trials Regulatory Process"}]},{"@type":"WebSite","@id":"https:\/\/credevo.com\/articles\/#website","url":"https:\/\/credevo.com\/articles\/","name":"Credevo","description":"","publisher":{"@id":"https:\/\/credevo.com\/articles\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/credevo.com\/articles\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/credevo.com\/articles\/#organization","name":"Credevo Pte. Ltd.","url":"https:\/\/credevo.com\/articles\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/credevo.com\/articles\/#\/schema\/logo\/image\/","url":"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2021\/04\/CREDEVO-HORIZONTAL.jpg","contentUrl":"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2021\/04\/CREDEVO-HORIZONTAL.jpg","width":320,"height":119,"caption":"Credevo Pte. Ltd."},"image":{"@id":"https:\/\/credevo.com\/articles\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/credevo","https:\/\/x.com\/gocredevo","https:\/\/www.instagram.com\/credevo_official\/","https:\/\/www.linkedin.com\/company\/credevo"]},{"@type":"Person","@id":"https:\/\/credevo.com\/articles\/#\/schema\/person\/eaf79e204cf3f6b11d8925cdd7adb3ed","name":"Feasibility Team","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/credevo.com\/articles\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/0f5b3e164715f8b2e66af0b776460d63?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0f5b3e164715f8b2e66af0b776460d63?s=96&d=mm&r=g","caption":"Feasibility Team"},"sameAs":["http:\/\/www.credevo.com"],"url":"https:\/\/credevo.com\/articles\/author\/fteam\/"}]}},"_links":{"self":[{"href":"https:\/\/credevo.com\/articles\/wp-json\/wp\/v2\/posts\/388"}],"collection":[{"href":"https:\/\/credevo.com\/articles\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/credevo.com\/articles\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/credevo.com\/articles\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/credevo.com\/articles\/wp-json\/wp\/v2\/comments?post=388"}],"version-history":[{"count":35,"href":"https:\/\/credevo.com\/articles\/wp-json\/wp\/v2\/posts\/388\/revisions"}],"predecessor-version":[{"id":10382,"href":"https:\/\/credevo.com\/articles\/wp-json\/wp\/v2\/posts\/388\/revisions\/10382"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/credevo.com\/articles\/wp-json\/wp\/v2\/media\/426"}],"wp:attachment":[{"href":"https:\/\/credevo.com\/articles\/wp-json\/wp\/v2\/media?parent=388"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/credevo.com\/articles\/wp-json\/wp\/v2\/categories?post=388"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/credevo.com\/articles\/wp-json\/wp\/v2\/tags?post=388"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}